// App-Quantinova.ai

: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOLLOWING DASATINIB-BASED TWO-STEP INDUCTION FOR PHILADELPHIA CHROMOSOME-POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA: RESULTS OF THE JALSG PH+ALL213 STUDY

Researchers

Presenter

  • Isamu Sugiura

Principal Investigators

  • Tomoko Hata

  • Ryuko Cho

  • Ito Toshiro

  • Suehiro Youko

  • Heiwa Kanamori

  • Shinichi Kako

  • Mitsuhiro Matsuda

  • Hisayuki Yokoyama

  • Yasuhiro Taniguchi

  • Maki Hagihara

  • Yukiya Ozawa

  • Shin Fujisawa

  • Yoshihiro Hatta

  • Nobuaki Dobashi

  • Satoshi Nishiwaki

  • Yoshiko Atsuta

  • Fumihiko Hayakawa

  • Shigeki Otake

  • Yasushi Miyazaki

Medical Centers

  • Division of Hematology and Oncology, Toyohashi Municipal Hospital, Toyohashi, Japan

  • Division of Hematology, Tokyo Metropolitan Cancer and Infectious diseases Center, Tokyo, Japan

  • Atomic Bomb Disease Institute, Nagasaki, Japan

  • Hematology,Saiseikai Narashino Hospital,Chiba,Japan

  • Hematology,Matsumoto Medical Center,Matsumoto,Japan

  • Hematology, National Kyusyu Cancer Center, Fukuoka, Japan

  • of Hematology, Kanagawa Cancer Center, Yokohama, Japan

  • Jichi Medical University, Saitama Medical Center, Saitama, Japan

  • Hematology, PL Hospital, Tondabayashi, Japan

  • Hematology,Sendai Medical Center,Sendai,Japan

  • Hematology and Rheumatology,Kindai University Hospital,Osakasayama,Japan

  • Department of Internal Medicine and Clinical Immunology, Yokohama City University Graduate School of Medicine, Yokohama, Japan

  • Japanese Red Cross Nagoya First Hospital, Nagoya, Japan

  • Yokohama City University Medical Center, Yokohama City, Japan

  • Department of Hematology and Rheumatology, Nihon University School of Medicine, Tokyo, Japan

  • Division of Clinical Oncology and Hematology, The Jikei University Hospital, Tokyo, Japan

  • Hematology and Oncology,Nagoya City University Hospital,Nagoya,Japan

  • Japanese Data Center for Hematopoietic Cell Transplantation,

  • School of Health Sciences, Nagoya University,Nagoya,Japan

  • Kanazawa University, Kanazawa, Japan

  • Department of Tumor and Diagnostic Pathology, Atomic Bomb Disease Institute, Nagasaki University, Nagasaki, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Philadelphia chromosome–positive (Ph+) ALL

Biomarkers

  • Breakpoint Cluster Region

  • Soluble Complement 5b-9

Drug/Treatment

  • dasatinib

Outcome

  • N/A

Study Design

  • Multicenteric

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved